Sponsor:
Novelwise Pharmaceutical Corporation
Code:
NCT07136181
Conditions
Metastatic Uveal Melanoma
Uveal Melanoma, Metastatic
Uveal Melanoma, Recurrent
Eye Cancer, Intraocular Melanoma
Eye Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
NBM-BMX Capsule are proprietary products developed by Novelwise Pharmaceutical Corporation (Novelwise) for treatment of patients suffering from cancers.
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-28. This information was provided to ClinicalTrials.gov by Novelwise Pharmaceutical Corporation on 2025-11-28.